...Il10). RBM at 10 mg/kg exhibited the most potent therapeutic effect: it significantly ameliorated BLM-induced weight los...
...IL10 and IL12B, indicating T cell activation and a regulatory immune reaction. To further characterize CD8⁺ T cell–speci...
...IL10) was reduced in both T2D (p = 0.0005), while in the OB group IL10 was not reduced after BMI adjustment. Importantly...
...IL10, CXCL12, and AKT1. Clinically, high DKK1 and CSF1 expression correlated with cisplatin resistance and poor prognosi...
...IL10, TNFα, and HMOX1 have been associated with angiogenesis, immune evasion, and poor treatment response. Emerging evid...
...IL10, CXCL2, CXCL8, PTGS2, NFE2L2, CYP19A1, and PPARA, while NF-κB signaling pathway was the key signaling pathway. Two ...
...IL10 in CAR T-cell response and toxicity. In this review, we summarize the history of these cytokines in immunotherapies...
...IL10 was found to be increased. The developed delivery system might have potential for clinical use in the treatment of ...
...Il10, Arg1), were also upregulated. Following ozone exposure, glycolytic activity and oxidative phosphorylation increase...
...Il10 expression. Selective depletion of interleukin-10-expressing (IL-10⁺) Treg cells promoted tumor growth by lifting t...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2025.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
